Clinical trial
Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study
NCT03194633 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 10, 2017
- Completion date
- August 28, 2020
- Enrollment
- 871 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.